Tajuana Looney, a 53-year-old grandmother from Gadsden, Alabama, underwent a groundbreaking seven-hour surgery to receive a genetically modified pig kidney. This operation was a last resort after she suffered kidney failure following a previous donation of her kidney to her mother and complications from high blood pressure during pregnancy. Despite being prioritized on the transplant list, high antibody levels made finding a compatible human donor nearly impossible. Her medical team received special FDA clearance to use a gene-edited pig kidney, which involved ten specific genetic modifications to make it compatible with human proteins. Looney is the fifth person in the U.S. to receive such a transplant, with previous patients not surviving long after the procedure. However, her relatively better health post-operation offers hope for the success of this experimental surgery. The medical community is closely monitoring her case to evaluate the feasibility of similar transplants for other patients. This case could potentially benefit the 100,000 people in the U.S. waiting for organ transplants.